Vaccine News and Research

Latest Vaccine News and Research

International study offers insight into occurrence of acute myocarditis during COVID-19 hospitalization

Acute myocarditis, inflammation of the heart muscle typically triggered by a virus, occurred in about two out of every 1,000 people hospitalized with COVID-19, and was associated with more severe illness and complications in people with COVID-19, especially among people who also had pneumonia, according to new research published today in the American Heart Association's flagship, peer-reviewed journal Circulation.

11 Apr 2022

MU researchers receive grant to increase confidence about COVID-19 vaccine among nurses

As an assistant teaching professor in the MU Sinclair School of Nursing, Stefanie Birk knows there are nursing students unsure of how to talk with people hesitant about getting a COVID-19 vaccine.

11 Apr 2022

Magic mushroom compound helps to 'open up' depressed people's brains after use

Psilocybin, the psychedelic compound found in magic mushrooms, helps to "open up" depressed people's brains, even after use, enabling brain regions to talk more freely to one another.

11 Apr 2022

Vaccines safely protect IBD patients from COVID-19

COVID-19 vaccines taken by people with inflammatory bowel disease (IBD), which affects millions worldwide, safely and effectively protects them from the SARS-Cov-2 virus, a Rutgers study finds.

11 Apr 2022

Prime-pull immunization of mice with novel subunit vaccine elicits mucosal immunity to prevent severe SARS CoV-2 infection

Researchers tested whether a subunit vaccine could generate mucosal immunity in mice and prevent SARS-CoV-2 infection and related pathology.

11 Apr 2022

SARS-CoV-2 Omicron BA.2 sublineage outbreak aggravated by low population immunity in Hong Kong

A new study illustrated that inadequate population immunity exacerbated the SARS-CoV-2 Omicron BA.2 sublineage outbreak in Hong Kong.

11 Apr 2022

The human antibody response to the SARS-CoV-2 spike protein N-terminal domain in a group of previously infected individuals

Researchers evaluated the human antibody response to the NTD of the S protein by investigating a group of individuals who had previously been infected with SARS-CoV-2 or who had received an mRNA vaccine.

11 Apr 2022

Study explores COVID-19 vaccine hesitancy among those with underlying medical conditions

In a recent study posted to the medRxiv* preprint server, researchers examined the coronavirus disease 2019 (COVID-19) vaccine uptake and hesitancy among people with chronic or severe health conditions.

11 Apr 2022

New research on SARS-CoV-2 Omicron variant mutations and sotrovimab therapy

A recent study posted to the medRxiv* preprint server assessed the impact of sotrovimab treatment on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant-infected immunocompromised (IC) patients.

11 Apr 2022

Vaccine-induced blood clots may be the result of genetics, study finds

The rare blood clot side-effect associated with some COVID-19 vaccines could be the result of genetics, new research has found, paving the way for a potential genetic screening test.

11 Apr 2022

Immunocompromised hosts with Delta/Omicron co-infections

A recent study posted to the medRxiv* preprint server examined clinical cases of co-infections of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta/Omicron variants and Omicron BA.1/ BA.2 sublineages in immunocompromised (IC) patients.

10 Apr 2022

CDC report on Omicron infections soon after Delta

A new study identifies ten patients with confirmed SARS-CoV-2 Omicron variant infections within 90 days of a previous Delta variant infection.

10 Apr 2022

Preliminary data from clinical trial reveals safety, efficacy of new CAR T-cell therapy for solid tumors

A new chimeric antigen receptor (CAR) T-cell product had an acceptable safety profile and showed early signs of efficacy as a monotherapy and in combination with an mRNA vaccine in patients with solid tumors, according to preliminary data from a phase I/II clinical trial presented during the AACR Annual Meeting 2022, held April 8-13.

10 Apr 2022

Computational network science approach reveals new mechanisms for coronaviruses infections

A group of bat viruses related to SARS-CoV-2 can also infect human cells but uses a different and unknown entryway.

8 Apr 2022

Study finds higher risk of thrombotic events after SARS-CoV-2 infection

A study from Sweden published by The BMJ today finds an increased risk of deep vein thrombosis (a blood clot in the leg) up to three months after covid-19 infection, pulmonary embolism (a blood clot in the lung) up to six months, and a bleeding event up to two months.

8 Apr 2022

Study explores the antibody evasion pattern of SARS-CoV-2 Omicron sublineages

Role of natural immunity to SARS-CoV-2 on post-vaccination antibody responses in staff and residents of long-term care facilities

A new study collected and analyzed sera from the staff at a local long-term care facility from August to December 2020, where an outbreak occurred in September 2020.

8 Apr 2022

Vaccine News and Research

Latest Vaccine News and Research

International study offers insight into occurrence of acute myocarditis during COVID-19 hospitalization

MU researchers receive grant to increase confidence about COVID-19 vaccine among nurses

Magic mushroom compound helps to 'open up' depressed people's brains after use

Vaccines safely protect IBD patients from COVID-19

Prime-pull immunization of mice with novel subunit vaccine elicits mucosal immunity to prevent severe SARS CoV-2 infection

SARS-CoV-2 Omicron BA.2 sublineage outbreak aggravated by low population immunity in Hong Kong

The human antibody response to the SARS-CoV-2 spike protein N-terminal domain in a group of previously infected individuals

Study explores COVID-19 vaccine hesitancy among those with underlying medical conditions

New research on SARS-CoV-2 Omicron variant mutations and sotrovimab therapy

Vaccine-induced blood clots may be the result of genetics, study finds

Immunocompromised hosts with Delta/Omicron co-infections

CDC report on Omicron infections soon after Delta

Preliminary data from clinical trial reveals safety, efficacy of new CAR T-cell therapy for solid tumors

Computational network science approach reveals new mechanisms for coronaviruses infections

Study finds higher risk of thrombotic events after SARS-CoV-2 infection

Study explores the antibody evasion pattern of SARS-CoV-2 Omicron sublineages

SARS-CoV-2 Omicron variant spike-specific unique cluster of differentiation cells

Evaluating immunogenicity after BNT162b2 booster vaccination

SARS-CoV-2 Delta-Omicron recombinant identified in a transplant patient treated with Sotrovimab

Role of natural immunity to SARS-CoV-2 on post-vaccination antibody responses in staff and residents of long-term care facilities

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in